Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 18Glioblastoma 3Carcinoma, Basal Cell 3Precancerous Conditions 2Gliosarcoma 2Brain Neoplasms 2Basal Cell Nevus Syndrome 2Skull Base Neoplasms 1Neurofibromatoses 1Neoplasms 1Mouth Neoplasms 1Meningioma 1Leukoplakia 1Head and Neck Neoplasms 1Glioma 1Erythroplasia 1Breast Neoplasms 1

Interventions

sonidegib 3tazarotene 2IPI-926 2HhAntag691 2Drug Evaluation 2Aminolevulinic Acid 2merphos 1Vincristine 1Solutions 1Red Light 1Photochemotherapy 1NVP-BKM120 1Methotrexate 1Mental Status and Dementia Tests 1Etoposide 1Cyclophosphamide 1Carboplatin 1Blue Light 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Basal Cell Nevus Syndrome × Aminolevulinic Acid × Clear all
NCT01556009 2020-11-02

Vismodegib

UCSF Benioff Children's Hospital Oakland

Phase 2 Completed
24 enrolled
Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT02157623 2020-07-30

Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome

The Cleveland Clinic

Phase NA Completed
3 enrolled 7 charts
Dermatologic

Basal Cell Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡